There is an increased expression of MR1 localized in MS-associated brain lesions regardless of the form of MS (i.e., Primary Progressive, Progressive Relapsing, Relapsing-Remitting, and Secondary Progressive) in which the patient presents. Here, MR1 is linked to myeloid sarcoma.